Sarcopenia and frailty are common geriatric clinical syndromes, commonly lead to falls, incapacity and death, and thus, affect the quality of life in the elderly. Therefore, sufficient attention should be paid to screening for sarcopenia and frailty. There are many screening methods for both of them at home and abroad, but there is still no unified golden standard. In recent years, with in-depth research, some new methods have been proposed for the screening of sarcopenia and frailty. This paper reviewed the research status and advancement of screening and evaluation methods for sarcopenia and frailty in order to discover and identify the 2 diseases early in clinical practice.